Francisco Cruz Coronel Díaz-rekin lankidetzan egindako argitalpenak (11)

2014

  1. Comment on "Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient"

    Nefrologia

2001

  1. Diabetic nephropathy: physiopathology and clinical course

    Nefrología : publicación oficial de la Sociedad Española Nefrologia, Vol. 21 Suppl 3, pp. 24-31

1997

  1. Calcium salts of keto-amino acids, a phosphate binder alternative for patients on CAPD

    Clinical Nephrology, Vol. 48, Núm. 3, pp. 181-184

1995

  1. Hiperlipidemia en el trasplante renal. Tratamiento con pantetina.

    Nefrologia, Vol. 15, Núm. 1, pp. 68-73

  2. Serum phosphate control: What about calcium salts of keto-amino acids?

    Nephrology Dialysis Transplantation, Vol. 10, Núm. 11, pp. 2159-2160

1991

  1. Fructosamine levels in CAPD: its value as glycemic index.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 7, pp. 253-256

  2. Peritoneal clearances, protein losses and ultrafiltration in diabetic patients after four years on CAPD.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 7, pp. 35-38

  3. Treatment of hyperlipidemia in diabetic patients on dialysis with a physiological substance

    American Journal of Nephrology, Vol. 11, Núm. 1, pp. 32-36

1990

  1. Diabetic patients on CAPD need less aluminum hydroxide as a phosphate binder than non-diabetics.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 6, pp. 50-52

  2. Partial Substitution of Sodium Lactate for Sodium Acetate in the Bath Fluid for Hemodialysis

    Artificial Organs, Vol. 14, Núm. 1, pp. 2-6

  3. SARCOMA DE KAPOSI ASOCIADO A TRASPLANTE RENAL

    Actas Dermo-Sifiliograficas, Vol. 81, Núm. 9, pp. 576-578